TESARO to Present at the 32nd Annual J.P. Morgan Healthcare Conference Print
GlobeNewswire
Tuesday, 07 January 2014 02:00

WALTHAM, Mass.--TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will attend the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.

Mr. Moulder will make a presentation at the conference on Thursday, January 16, 2014 at 1:30 p.m. Pacific time.

A live webcast will be accessible via the Investors page of the

TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the

Error. Page cannot be displayed. Please contact your service provider for more details. (14)

Company's website for 14 days after the
conference.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: Jennifer Davis          Sr. Director, Corporate Development & Investor Relations          1.781.325.1116          jdavis@tesarobio.com

TESARO, Inc. Logo




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
  BMR:1